2025 Cancer Updates GU and Heme
Learn How to Claim Your Credit
The Cancer Updates Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GU Cancers & Hematological Malignancies. Each agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.
Event Page
Accreditation Information | 1.75
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prio
-
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be
attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education
credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine
course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by
Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council
for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to
provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.
JA4008163-9999-25-249-L01-P | JA4008163-9999-25-249-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request
your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.
Learner Notification
Objectives - After Attending This Program You Should Be Able To
1. Determine best application of new targeted therapies in patients with early-stage and metastatic disease
2. Discuss the advances in systemic therapy likely to change current practices for treatment of lung cancer
3. Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that
each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a
conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name Commercial Interest:Relationship
manojkumar bupathi NA
Laura Graham Johnson & Johnson, Merck, Pfizer:Research Grant Site Principal Investigator
Tara Gregory NA
Jeffrey Matous
no others:Other
johnson & johnson:Consultant
Erin Schwab INCYTE, Natera:Speakers Bureau
Daniel Sherbenou Karyopharm:Research Grant Overall Principal Investigator
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
1. Go to thc.cmecertificateonline.com
2. Click on the Cancer Updates Heme and GU link.
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.co
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com